Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Live Oak Bancshares heads into its October 21 earnings report with analysts trimming targets and the stock down almost 8% over the past month, even as bulls argue the SBA-focused franchise remains structurally undervalued.
The most pressing story this week is the analyst tape. Two firms moved targets lower in the days surrounding this note. Piper Sandler cut its target from $46 to $38, just above where the stock currently trades at $36.49, while maintaining a Neutral rating. TD Cowen, which stays bullish with a Buy, pulled its target down to $44 from $49. Those moves pushed the Street consensus price target to $43.50, implying about 19% upside from current levels. The direction of recent revisions is unmistakably lower: after a round of post-Q2 upgrades in late July lifted targets across the board, the past two weeks have seen those gains handed back. That compression of the target range, from $47 to $49 down to $38 to $44, captures the Street's uncertainty ahead of the print rather than a change of fundamental conviction.
The bull and bear cases are well defined. Bears point to a net charge-off ratio of 0.80%, non-performing assets rising to 3.00% of total assets, and CET1 slipping to 10.42%, all of which leave the bank exposed if small business credit conditions deteriorate further. SBA guaranteed loan sale income of $17.6 million also disappointed against expectations. Bulls counter that net interest margins are holding in the 3.30% to 3.35% range, loan pipelines are near a record $4.6 billion, and noninterest-bearing deposits are up 43% year on year, giving the funding base more resilience than it appears. The valuation math adds context: the stock trades at roughly 9.3 times trailing earnings and 1.2 times book, modest multiples for a bank with low-teen loan growth. The EPS momentum factor scores are genuinely strong, ranking in the 86th and 90th percentiles on 30-day and 90-day measures, though the 12-month forward earnings growth score is a weak 22nd percentile, suggesting near-term momentum has not translated into upgraded full-year expectations.
Positioning in the borrow market is the least interesting angle on this stock right now. Short interest is running at 4.6% of the free float, a moderate level that has edged up about 0.8% over the past week but remains well below anything that would signal a crowded short. Borrow availability is extremely loose, with roughly 955% availability, meaning there are nearly ten shares available to lend for every one already borrowed. Cost to borrow has ticked up 8% on the week but remains at just 0.43 annually, placing it firmly in the low-cost category. Options tell a different story. The put/call ratio is at 0.018, the lowest reading of the past 52 weeks and nearly a full standard deviation below the 20-day average of 0.29. That extreme skew toward calls reflects either strong speculative demand for upside exposure into earnings or a collapse in put protection buying, neither of which reads as typical caution ahead of a quarterly print where credit quality is the swing factor.
Insider activity deserves attention, though the context matters. CEO James Mahan has sold roughly 50,000 shares since late August at prices in the $38 to $40 range, for a combined value near $1.6 million, all under a pre-arranged 10b5-1 plan. Plan-based sales are scheduled in advance and carry less signal than discretionary open-market transactions. Director Bradford Tonya Williams sold 1,600 shares on September 3 outside of a 10b5-1 plan, a smaller but more discretionary move. Net insider selling across all insiders over the past 90 days totals nearly 146,000 shares worth roughly $6 million. Mahan also remains the second-largest holder of the company with around 6.2 million shares, per the most recent institutional register, so the selling represents a trim rather than an exit. The FDIC call report data, via the Federal Deposit Insurance Corporation's quarterly bank filings, shows total assets rising for nine consecutive quarters to $16.5 billion and total deposits rising for the same stretch to $15.2 billion, streaks that confirm balance sheet momentum even if credit quality has softened at the margin.
With earnings due on October 21, the key variable is whether credit normalization stays within management's guided range of $20 million to $25 million in net charge-offs, or whether the recent NPA deterioration signals something more persistent in the small business loan book.
See the live data behind this article on ORTEX.
Open LOB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
